Pathway Genomics Adds The Honorable Dan Glickman, Former US Cabinet Member and Member of Congress, to Strategic Advisory Board

SAN DIEGO--(BUSINESS WIRE)--Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services globally, announced that former U.S. Representative and Secretary of Agriculture Dan Glickman joined its strategic advisory board.

"We're honored to have Secretary Glickman as part of our advisory board," said Jim Plante, Pathway Genomics' founder and CEO. "In his 25 years in public service in Congress and as an advisor to the President as Cabinet Member, Dan Glickman distinguished himself as a solutions-oriented leader with impeccable integrity. His many accomplishments over that time speak for themselves, and we are extremely fortunate to now benefit from his vast experience."

Prior to his appointment as Secretary of Agriculture from 1995 until 2001, Glickman served for 18 years in the U.S. House of Representatives representing the 4th Congressional District of Kansas. During his tenure in the House, Glickman emphasized the roles of diet and nutrition in preventing diseases and promoting public health. In 2012 and 2013, Glickman chaired an Institute of Medicine Panel on "Accelerating Progress in Obesity Prevention."

"From a national perspective, I've been an advocate for increased prevention as it is clear by all measures that an ounce of prevention is worth a pound of cure," said Glickman. "Genetics is the new frontier on prevention and Pathway is at the forefront of bringing this new information to physicians so that they can identify the best prevention program for a patient based on their overall risk factors."

Glickman served as Chairman of the Motion Picture Association of America, Inc. (MPAA) from 2004 until 2010, and is the Executive Director of the Aspen Institute Congressional Program, a nongovernmental, nonpartisan educational program for members of the United States Congress.

About Pathway Genomics Corporation

As a CLIA and CAP accredited clinical laboratory based in San Diego, California, Pathway Genomics provides physicians with actionable and accurate genetic information to improve or maintain health and wellness of their patients. Since its founding in 2008, Pathway Genomics has become known for its dedication to innovation and commitment to medical responsibility – making it a leader in the commercial genetic testing industry.

Pathway Genomics' testing services cover a variety of conditions including cancer risk, cardiac health, inherited diseases, nutrition and exercise response, as well as drug response for specific medications including those used in pain management and mental health. For more about Pathway Genomics, visit www.pathway.com.

Suggested Articles

As Relay looks to enter the clinic in 2020, the company is adding a trio of biopharma vets to its leadership team.

A phase 3 trial of Myovant Sciences’ relugolix in prostate cancer has met its primary endpoint, teeing the company up to file for FDA approval.

The Medicines Company, fresh from its turn at the AHA this weekend, has seen its shares jump on growing rumors that Novartis wants to acquire it.